SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-052592
Filing Date
2005-03-16
Accepted
2005-03-16 15:10:24
Documents
8
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1222188
2 SUBSIDIARIES OF THE COMPANY dex21.htm EX-21 2284
3 CONSENT OF KPMG LLP dex231.htm EX-23.1 3311
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex232.htm EX-23.2 1845
5 CERTIFICATION OF CEO dex311.htm EX-31.1 9985
6 CERTIFICATION OF CFO dex312.htm EX-31.2 10008
7 CERTIFICATION OF CEO dex321.htm EX-32.1 4361
8 CERTIFICATION OF CFO dex322.htm EX-32.2 4402
  Complete submission text file 0001193125-05-052592.txt   1260750
Mailing Address 650 COLLEGE RD EAST STE 3100 PRINCETON NJ 08540
Business Address 650 COLLEGE RD EAST STE 3100 PRINCETON NJ 08540 6099878200
CYTOGEN CORP (Filer) CIK: 0000725058 (see all company filings)

IRS No.: 222322400 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-14879 | Film No.: 05685088
SIC: 2834 Pharmaceutical Preparations